310 related articles for article (PubMed ID: 1333465)
1. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
Naito M; Satake M; Sakai E; Hirano Y; Tsuchida N; Kanzaki H; Ito Y; Mori T
Jpn J Cancer Res; 1992 Oct; 83(10):1030-6. PubMed ID: 1333465
[TBL] [Abstract][Full Text] [Related]
2. Involvement of p53 gene mutations in human endometrial carcinomas.
Honda T; Kato H; Imamura T; Gima T; Nishida J; Sasaki M; Hoshi K; Sato A; Wake N
Int J Cancer; 1993 Apr; 53(6):963-7. PubMed ID: 8473053
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
4. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
6. Direct cycle sequencing of mutated alleles detected by PCR single-strand conformation polymorphism analysis.
Mok SC; Lo KW; Tsao SW
Biotechniques; 1993 May; 14(5):790-4. PubMed ID: 8512704
[TBL] [Abstract][Full Text] [Related]
7. ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Katsuragi K; Kinoshita M; Saito S; Itakura M
Jpn J Cancer Res; 1992 Oct; 83(10):1057-62. PubMed ID: 1452458
[TBL] [Abstract][Full Text] [Related]
8. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
[TBL] [Abstract][Full Text] [Related]
9. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
[TBL] [Abstract][Full Text] [Related]
10. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
Tsuda H; Hirohashi S
Jpn J Cancer Res; 1992 Nov; 83(11):1184-91. PubMed ID: 1336492
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-based polymerase chain reaction-single-strand conformation polymorphism analysis of p53 gene by capillary electrophoresis.
Katsuragi K; Kitagishi K; Chiba W; Ikeda S; Kinoshita M
J Chromatogr A; 1996 Sep; 744(1-2):311-20. PubMed ID: 8843680
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations in human endometrial carcinoma.
Risinger JI; Dent GA; Ignar-Trowbridge D; McLachlan JA; Tsao MS; Senterman M; Boyd J
Mol Carcinog; 1992; 5(4):250-3. PubMed ID: 1497800
[TBL] [Abstract][Full Text] [Related]
14. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.
Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE
Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations in ovarian cancer: a late event?
Mazars R; Pujol P; Maudelonde T; Jeanteur P; Theillet C
Oncogene; 1991 Sep; 6(9):1685-90. PubMed ID: 1923532
[TBL] [Abstract][Full Text] [Related]
18. Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.
Kohler MF; Nishii H; Humphrey PA; Saski H; Marks J; Bast RC; Clarke-Pearson DL; Boyd J; Berchuck A
Am J Obstet Gynecol; 1993 Sep; 169(3):690-4. PubMed ID: 8372881
[TBL] [Abstract][Full Text] [Related]
19. Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.
Niwa K; Itoh M; Murase T; Morishita S; Itoh N; Mori H; Tamaya T
Br J Cancer; 1994 Dec; 70(6):1191-7. PubMed ID: 7981076
[TBL] [Abstract][Full Text] [Related]
20. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
